CVS Caremark (CVS) Tops Q2 EPS by 1c; Narrows FY Outlook
Tweet Send to a Friend
CVS Caremark (NYSE: CVS) reported Q2 EPS of $0.97, $0.01 better than the analyst estimate of $0.96. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
